Published in Gene Therapy Weekly, April 10th, 1995
In an address to the Third Annual Vaccines: New Technologies and Applications Conference, held March 20-22 in Alexandria, Virginia, Goldenthal noted that current areas of vaccine development include new combination vaccines, less reactogenic vaccines, novel adjuvants, polysaccharide conjugate vaccines, and new clinical indications for existing vaccines.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly